Author Correction: EZH2-mediated loss of miR-622 determines CXCR4 activation in hepatocellular carcinoma
Guardado en:
Autores principales: | Haiou Liu, Yidong Liu, Weisi Liu, Weijuan Zhang, Jiejie Xu |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/5fb15175701c43e6a1246427b4bab00d |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Loss of miR-100 and miR-125b results in cancer stem cell properties through IGF2 upregulation in hepatocellular carcinoma
por: Hyang Sook Seol, et al.
Publicado: (2020) -
MiR-18a-5p Facilitates Progression of Hepatocellular Carcinoma by Targeting CPEB3
por: Mingxin Cui MM, et al.
Publicado: (2021) -
The miR-125a/HK2 axis regulates cancer cell energy metabolism reprogramming in hepatocellular carcinoma
por: Fangfang Jin, et al.
Publicado: (2017) -
EZH1/2 inhibition augments the anti-tumor effects of sorafenib in hepatocellular carcinoma
por: Yuko Kusakabe, et al.
Publicado: (2021) -
Circ_0091579 enhances the malignancy of hepatocellular carcinoma via miR-1287/PDK2 axis
por: Shu Junwei, et al.
Publicado: (2021)